Our previous data using CRC cell lines and organoids showed that USP7 is essential for pathological WNT activation in APC mutant cells but not physiological WNT signaling in normal cells, suggesting that USP7 can be used as tumor-specific drug target (Novellasdemunt et al., 2017). This evidence concerns the gene USP7 and neoplasm.